These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 870773)
21. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects. Wisgerhof M; Brown RD J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808 [TBL] [Abstract][Full Text] [Related]
22. [Behavior of the plasma renin activity and aldosterone after salt restriction and upright posture in essential hypertension]. Kokot F; Kuska J; Chorqzy M Z Gesamte Inn Med; 1976 Dec; 31(24):1016-20. PubMed ID: 1020406 [TBL] [Abstract][Full Text] [Related]
23. [Is there a relation between the renin-angiotensin-aldosterone system and vasopressin secretion in essential hypertension?]. Wiecek A; Kokot F Z Gesamte Inn Med; 1984 Dec; 39(23):578-82. PubMed ID: 6396982 [TBL] [Abstract][Full Text] [Related]
24. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism. Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332 [TBL] [Abstract][Full Text] [Related]
25. Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension. Takeda R; Morimoto S; Uchida K; Hashiba T; Kigoshi T; Honjo A; Fujimura A Clin Exp Hypertens A; 1982; 4(6):937-49. PubMed ID: 7047005 [TBL] [Abstract][Full Text] [Related]
26. Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes. Douglas J; Catt KJ J Clin Invest; 1976 Oct; 58(4):834-43. PubMed ID: 965491 [TBL] [Abstract][Full Text] [Related]
27. Abnormal norepinephrine and aldosterone responses to upright posture in nonmodulating hypertension. Conlin PR; Braley LM; Menachery AI; Hollenberg NK; Williams GH J Clin Endocrinol Metab; 1992 Oct; 75(4):1017-21. PubMed ID: 1400865 [TBL] [Abstract][Full Text] [Related]
28. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake. Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530 [TBL] [Abstract][Full Text] [Related]
29. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890 [TBL] [Abstract][Full Text] [Related]
30. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261 [TBL] [Abstract][Full Text] [Related]
31. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension. Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868 [TBL] [Abstract][Full Text] [Related]
32. Influence of sodium intake on the reliability of active renin as a measure of the renin-angiotensin system in essential hypertension. Hurwitz S; Potter B; Weiss RJ; Jeunemaitre X; Hopkins PN; Hunt SC; Litchfield WR; Williams GH Am J Clin Pathol; 2001 Feb; 115(2):304-12. PubMed ID: 11211621 [TBL] [Abstract][Full Text] [Related]
33. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis. Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031 [TBL] [Abstract][Full Text] [Related]
34. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man. Williams GH; Braley LM; Underwood RH J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059 [TBL] [Abstract][Full Text] [Related]
35. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571 [TBL] [Abstract][Full Text] [Related]
37. The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension. Saito I; Saruta T; Nakamura R; Misumi J; Kondo K; Matsuki S Jpn Circ J; 1976 Aug; 40(8):911-9. PubMed ID: 184308 [TBL] [Abstract][Full Text] [Related]
38. A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension. Tuck ML; Williams GH; Dluhy RG; Greenfield M; Moore TJ Circ Res; 1976 Nov; 39(5):711-7. PubMed ID: 975459 [TBL] [Abstract][Full Text] [Related]
39. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension. Williams GH; Hollenberg NK J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876 [TBL] [Abstract][Full Text] [Related]
40. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man. Speckart P; Zia P; Zipser R; Horton R J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]